Ruth Lynfield

Q: What Schools Are Affiliated With Ruth Lynfield

Ruth Lynfield is affiliated with the following schools: Emory University, Massachusetts General Hospital

Ruth Lynfield's AcademicInfluence.com Rankings

Ruth Lynfield

Philosophy

#7330

World Rank

#10526

Historical Rank

Logic

#4389

World Rank

#5673

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Ruth Lynfield's Degrees

Doctorate Medicine University of Minnesota

Why Is Ruth Lynfield Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ruth Lynfield's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Invasive methicillin-resistant Staphylococcus aureus infections in the United States. (2007) (3749)
Multistate point-prevalence survey of health care-associated infections. (2014) (2844)
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 (2020) (2045)
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. (2003) (1827)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. (2003) (1550)
Methicillin-resistant Staphylococcus aureus disease in three communities. (2005) (1542)
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. (2016) (1192)
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. (2010) (872)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. (2006) (839)
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. (2007) (766)
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. (2008) (687)
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. (2005) (674)
Combating antimicrobial resistance: policy recommendations to save lives. (2011) (655)
Bacterial meningitis in the United States, 1998-2007. (2005) (641)
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study (2006) (602)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. (2015) (596)
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. (2002) (574)
Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals (2018) (536)
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. (2007) (476)
Vital Signs: Carbapenem-Resistant Enterobacteriaceae (2013) (472)
National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. (2013) (455)
Health care-associated invasive MRSA infections, 2005-2008. (2010) (416)
Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. (2009) (402)
Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. (1994) (402)
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020 (2020) (392)
Epidemiology of Invasive Early-Onset Neonatal Sepsis, 2005 to 2014 (2016) (301)
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. (2010) (298)
The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008 (2011) (297)
Evaluation of universal antenatal screening for group B streptococcus. (2009) (295)
Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. (2014) (279)
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. (2015) (268)
Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020 (2020) (259)
Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012. (2016) (244)
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States (2003) (226)
Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020. (2020) (223)
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021 (2021) (211)
Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. (2012) (202)
Hospitalizations Associated with COVID-19 Among Children and Adolescents — COVID-NET, 14 States, March 1, 2020–August 14, 2021 (2021) (199)
Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. (2009) (194)
Community-associated Methicillin-resistant Staphylococcus aureus and Healthcare Risk Factors (2006) (192)
Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. (2004) (186)
Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance (2019) (180)
Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multistate, Population-Based Analysis (2008) (179)
Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal Immunization (2006) (178)
Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020 (2020) (174)
Excess Costs and Utilization Associated with Methicillin Resistance for Patients with Staphylococcus aureus Infection (2010) (170)
Recommendations from the National Vaccine Advisory Committee: Standards for Adult Immunization Practice (2014) (165)
Trends in perinatal group B streptococcal disease - United States, 2000-2006. (2009) (152)
Outbreak of Variant Influenza A(H3N2) Virus in the United States (2013) (150)
Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. (2011) (149)
Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping — United States, 2019 (2019) (146)
Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children: 2003–2004 (2006) (145)
Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus (2013) (138)
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study. (2016) (134)
Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates (2009) (133)
Characterization of Methicillin-Resistant Staphylococcus aureus Isolates Collected in 2005 and 2006 from Patients with Invasive Disease: a Population-Based Analysis (2009) (133)
Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza (2017) (132)
Toxoplasmosis-Related Knowledge and Practices Among Pregnant Women in the United States (2003) (127)
Staphylococcal Toxic Shock Syndrome 2000–2006: Epidemiology, Clinical Features, and Molecular Characteristics (2011) (126)
Management of Infants at Risk for Group B Streptococcal Disease (2019) (126)
Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016 (2018) (121)
Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. (2012) (119)
Prenatal screening for infectious diseases and opportunities for prevention. (2003) (119)
Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. (2010) (117)
Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. (2010) (116)
Varicella in pediatric renal transplant recipients. (1992) (113)
Trends in Invasive Methicillin-Resistant Staphylococcus aureus Infections (2013) (113)
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. (2010) (111)
Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. (2010) (110)
Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. (2013) (108)
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021 (2021) (108)
Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016 (2019) (108)
Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. (2014) (107)
Outbreak of Osteomyelitis/Septic Arthritis Caused by Kingella kingae Among Child Care Center Attendees (2005) (105)
Racial and Ethnic Disparities in Rates of COVID-19–Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021 (2021) (103)
A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates (2003) (103)
Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022 (2022) (101)
Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States. (2016) (100)
Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA. (2017) (99)
Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. (2014) (98)
Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015 (2017) (93)
Characteristics of E-cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement — Minnesota, 2018 and 2019 (2019) (92)
Complications Among Adults Hospitalized With Influenza: A Comparison of Seasonal Influenza and the 2009 H1N1 Pandemic (2014) (92)
Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine. (2016) (92)
Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States. (2010) (90)
Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. (2011) (90)
Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007. (2008) (89)
Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, October 2019 (2019) (89)
Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease—United States, 2009–2014 (2016) (89)
COVID-19–Associated Hospitalizations Among Health Care Personnel — COVID-NET, 13 States, March 1–May 31, 2020 (2020) (89)
Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011. (2013) (87)
An Outbreak of Measles in an Undervaccinated Community (2014) (87)
Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System (2020) (86)
Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease—United States, 2009–2015 (2018) (85)
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. (2009) (83)
Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003 (2005) (81)
Virulence Genes and Genotypic Associations in Nasal Carriage, Community-Associated Methicillin-Susceptible and Methicillin-Resistant USA400 Staphylococcus aureus Isolates (2010) (81)
Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism. (2012) (78)
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization (2010) (77)
Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (2022) (76)
Vaccine-derived poliomyelitis 12 years after infection in Minnesota. (2011) (76)
Children With Asthma Hospitalized With Seasonal or Pandemic Influenza, 2003–2009 (2011) (76)
USA300 and USA500 Clonal Lineages of Staphylococcus aureus Do Not Produce a Capsular Polysaccharide Due to Conserved Mutations in the cap5 Locus (2015) (75)
Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use (2010) (75)
Update: Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injuries — United States, December 2019 (2019) (73)
Hospitalization of Adolescents Aged 12–17 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021 (2021) (72)
Comparing Pulsed-Field Gel Electrophoresis with Multilocus Sequence Typing, spa Typing, Staphylococcal Cassette Chromosome mec (SCCmec) Typing, and PCR for Panton-Valentine Leukocidin, arcA, and opp3 in Methicillin-Resistant Staphylococcus aureus Isolates at a U.S. Medical Center (2012) (71)
Clinical guidance for smallpox vaccine use in a postevent vaccination program. (2015) (70)
Viruses Associated With Acute Respiratory Infections and Influenza-like Illness Among Outpatients From the Influenza Incidence Surveillance Project, 2010–2011 (2013) (70)
Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019 (2019) (70)
Update: Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, August 2019–January 2020 (2020) (68)
The US Influenza Hospitalization Surveillance Network (2015) (66)
The Burden of Influenza Hospitalizations in Infants From 2003 to 2012, United States (2014) (66)
Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010 (2013) (65)
Influenza-Associated Pneumonia in Children Hospitalized With Laboratory-Confirmed Influenza, 2003–2008 (2010) (62)
Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. (2011) (61)
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (2022) (60)
Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks — Minnesota, April–June 2020 (2020) (59)
Social determinants of influenza hospitalization in the United States (2016) (59)
Community-Associated Methicillin-Resistant Staphylococcus aureus: Trends in Case and Isolate Characteristics from Six Years of Prospective Surveillance (2009) (58)
Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13. (2015) (58)
Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae (2015) (58)
The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies (2013) (57)
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. (2013) (57)
Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic — United States, March–April 2021 (2021) (57)
Infectious disease surveillance. (2007) (57)
From the Centers for Disease Control and Prevention: early-onset group B streptococcal disease--United States, 1998-1999. (2000) (57)
Serotype IV and Invasive Group B Streptococcus Disease in Neonates, Minnesota, USA, 2000–2010 (2013) (56)
Listeriosis prevention knowledge among pregnant women in the USA. (2005) (55)
Early-Onset Group B Streptococcal Disease in the United States: Potential for Further Reduction (2014) (55)
Plasmid-Borne erm(T) from Invasive, Macrolide-Resistant Streptococcus pyogenes Strains (2008) (54)
Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic — United States, March–April 2021 (2021) (53)
Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection—United States, 2005–2008 (2015) (53)
Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008. (2009) (53)
Risk Factors for Household Transmission of Community-associated Methicillin-resistant Staphylococcus aureus (2011) (52)
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015 (2018) (51)
Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected lyme disease. (2010) (47)
Community-Acquired Methicillin-Resistant (2004) (47)
Twenty Years of Active Bacterial Core Surveillance (2015) (47)
Estimated Burden of Community-Onset Respiratory Syncytial Virus–Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014–15 (2019) (47)
Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015 (2016) (47)
Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine (2017) (46)
Clinician Knowledge and Beliefs after Statewide Program to Promote Appropriate Antimicrobial Drug Use (2005) (46)
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021 (2021) (46)
Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. (2012) (45)
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. (2011) (44)
Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003. (2006) (44)
Clonal Dissemination of Enterobacter cloacae Harboring blaKPC-3 in the Upper Midwestern United States (2015) (43)
Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. (2003) (43)
Epidemiology of Infant Meningococcal Disease in the United States, 2006-2012 (2015) (42)
Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017. (2020) (41)
Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period. (2012) (41)
Evaluation of New Biomarker Genes for Differentiating Haemophilus influenzae from Haemophilus haemolyticus (2012) (39)
Lessons Learned from the 1918–1919 Influenza Pandemic in Minneapolis and St. Paul, Minnesota (2007) (38)
An outbreak of Pontiac fever with respiratory distress among workers performing high-pressure cleaning at a sugar-beet processing plant. (2005) (38)
Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States. (2013) (38)
Benefit of Early Initiation of Influenza Antiviral Treatment to Pregnant Women Hospitalized With Laboratory-Confirmed Influenza. (2016) (37)
Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States. (2020) (37)
Live Animal Markets in Minnesota: A Potential Source for Emergence of Novel Influenza A Viruses and Interspecies Transmission. (2015) (37)
Risk Factors for Meningococcal Disease in Students in Grades 9–12 (2008) (37)
Medical Versus Nonmedical Immunization Exemptions for Child Care and School Attendance (2016) (37)
Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015. (2019) (37)
Influenza Immunization for All Health Care Personnel: Keep It Mandatory (2015) (36)
Characteristics of Patients Experiencing Rehospitalization or Death After Hospital Discharge in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, 2019 (2020) (36)
Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. (2013) (36)
Cancers-associated with HIV infection. (1987) (35)
Assessment of the Appropriateness of Antimicrobial Use in US Hospitals (2021) (35)
Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults (2020) (35)
Invasive Group A Streptococcal Infection in Older Adults in Long-term Care Facilities and the Community, United States, 1998–20031 (2007) (34)
Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies (2014) (34)
Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older (2016) (33)
Multistate population and whole genome sequence based strain surveillance of invasive pneumococci recovered in the United States during 2017. (2020) (33)
A Community Outbreak of Conjunctivitis Caused by Nontypeable Streptococcus pneumoniae in Minnesota (2006) (33)
Recommendations for Prevention and Control of Influenza in Children, 2015–2016 (2015) (31)
Obesity not associated with severity among hospitalized adults with seasonal influenza virus infection (2015) (31)
Increase in rates of hospitalization due to laboratory-confirmed influenza among children and adults during the 2009-10 influenza pandemic. (2012) (31)
Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic. (2012) (31)
Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011. (2020) (31)
Invasive Group B Streptococcal Disease in the Elderly, Minnesota, USA, 2003–2007 (2008) (31)
Identifying Host Genetic Risk Factors in the Context of Public Health Surveillance for Invasive Pneumococcal Disease (2011) (30)
Rifampin-resistant Meningococcal Disease (2005) (29)
Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013. (2016) (29)
Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015 (2017) (28)
Outbreak of Trichinella spiralis infections associated with a wild boar hunted at a game farm in Iowa. (2014) (28)
Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure, United States, 2005-2013. (2019) (28)
Respiratory and Nonrespiratory Diagnoses Associated With Influenza in Hospitalized Adults (2020) (28)
Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin-Intermediate S. aureus Phenotype (2011) (27)
Prevalence of Antimicrobial Use and Opportunities to Improve Prescribing Practices in U.S. Nursing Homes. (2016) (27)
Epidemiologic Investigation of Immune-Mediated Polyradiculoneuropathy among Abattoir Workers Exposed to Porcine Brain (2010) (27)
Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States. (2009) (27)
Assessment of Health Care Exposures and Outcomes in Adult Patients With Sepsis and Septic Shock (2020) (27)
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022 (2022) (26)
Toxoplasmosis prevention knowledge among pregnant women in Minnesota. (2005) (25)
Non-mumps Viral Parotitis During the 2014–2015 Influenza Season in the United States (2018) (24)
Ocular Monkeypox — United States, July–September 2022 (2022) (24)
Pathological findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury (EVALI): a case series. (2020) (24)
Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers--Connecticut and Minnesota, 1998. (2000) (24)
Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019 (2021) (24)
Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls (2010) (24)
Haemophilus influenzae type b infection, vaccination, and H. influenzae carriage in children in Minnesota, 2008–2009 (2011) (24)
First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota — December 2020–January 2021 (2021) (24)
Infectious disease surveillance: A cornerstone for prevention and control (2013) (23)
Hospital-onset influenza hospitalizations--United States, 2010-2011. (2014) (23)
Influenza-associated Hospitalizations by Industry, 2009–10 Influenza Season, United States (2012) (23)
First Identified Cases of SARS-CoV-2 Variant P.1 in the United States — Minnesota, January 2021 (2021) (23)
Cost of screening intensive care unit patients for methicillin-resistant Staphylococcus aureus in hospitals. (2011) (22)
Detection of Influenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013–2016 (2017) (22)
Protecting the Public's Health: Critical Functions of the Section 317 Immunization Program—A Report of the National Vaccine Advisory Committee (2013) (22)
Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001 (2005) (21)
Guidelines to Implement Medical Examiner/Coroner-Based Surveillance for Fatal Infectious Diseases and Bioterrorism ("Med-X") (2010) (21)
Public Health Importance of Invasive Methicillin-sensitive Staphylococcus aureus Infections: Surveillance in 8 US Counties, 2016. (2019) (21)
Design and Implementation of a Statewide Influenza Nurse Triage Line in Response to Pandemic H1N1 Influenza (2012) (21)
Examining the role of different age groups, and of vaccination during the 2012 Minnesota pertussis outbreak (2015) (20)
Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults. (2015) (20)
Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009. (2014) (20)
Clinical Laboratory Response to a Mock Outbreak of Invasive Bacterial Infections: a Preparedness Study (2014) (20)
Measuring Antibiotic Appropriateness for Urinary Tract Infections in Nursing Home Residents (2017) (20)
Infectious Disease Surveillance: M'ikanatha/Infectious (2013) (20)
Clonal Lineages of Staphylococcus aureus Do Not Produce a Capsular Polysaccharide Due to Conserved Mutations in the cap 5 Locus (20)
Heavy alcohol use as a risk factor for severe outcomes among adults hospitalized with laboratory-confirmed influenza, 2005–2012 (2014) (20)
Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022 (2022) (19)
Complete Genome Sequence of a Carbapenem-Resistant Extraintestinal Pathogenic Escherichia coli Strain Belonging to the Sequence Type 131 H30R Subclade (2015) (19)
Foodborne outbreak of group a streptococcus pharyngitis associated with a high school dance team banquet--Minnesota, 2012. (2013) (19)
A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee (2016) (19)
Hospital-based policies for prevention perinatal Group B streptococcal disease--United States, 1999. (2000) (18)
Antimicrobial Use in a Cohort of US Nursing Homes, 2017. (2021) (18)
Screening methods for congenital toxoplasma and risk of disease (1999) (18)
Satisfaction and Public Health Cost of a Statewide Influenza Nurse Triage Line in Response to Pandemic H1N1 Influenza (2013) (18)
Investigation of Inhalation Anthrax Case, United States (2014) (18)
COVID-19-associated hospitalizations among vaccinated and unvaccinated adults >=18 years - COVID-NET, 13 states, January 1 - July 24, 2021 (2021) (18)
Antibiotic and Infection Tracking in Minnesota Long‐Term Care Facilities (2007) (17)
Multilaboratory Evaluation of Disk Diffusion Antimicrobial Susceptibility Testing of Neisseria meningitidis Isolates (2006) (17)
Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates (2015) (17)
Public Health Surveillance for Infectious Diseases (2010) (17)
Multistate Outbreak of Melioidosis Associated with Imported Aromatherapy Spray. (2022) (17)
Patterns of antibiotic nonsusceptibility among invasive group A Streptococcus infections-United States, 2006-2017. (2021) (17)
Policy Statement: Antibiotic Stewardship in Pediatrics. (2021) (16)
Combating antibiotic resistance: a survey on the antibiotic-prescribing habits of dentists. (2018) (16)
Hepatitis A Infection in Recent International Adoptees and Their Contacts in Minnesota, 2007–2009 (2011) (16)
Epidemiology of Invasive Haemophilus influenzae Serotype a Disease-United States, 2008-2017. (2020) (16)
Influenza testing and antiviral prescribing practices among emergency department clinicians in 9 states during the 2006 to 2007 influenza season. (2010) (16)
A Case of Lassa Fever Diagnosed at a Community Hospital—Minnesota 2014 (2018) (16)
Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011-2015. (2018) (15)
Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis. (2009) (15)
Invasive group a streptococcal disease in nursing homes, Minnesota, 1995-2006. (2008) (15)
Burdens of Invasive Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Disease, Minnesota, USA (2019) (15)
Child, Household, and Caregiver Characteristics Associated with Hospitalization for Influenza Among Children 6–59 Months of Age (2014) (15)
Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S. (2016) (15)
Genomic Surveillance of Streptococcus pyogenes Strains Causing Invasive Disease, United States, 2016–2017 (2020) (15)
Randomized controlled trial of a self-administered five-day antiseptic bundle versus usual disinfectant soap showers for preoperative eradication of Staphylococcus aureus colonization (2018) (15)
Epidemiology of Antibiotic Use for Urinary Tract Infection in Nursing Home Residents. (2019) (14)
Variant Influenza Associated with Live Animal Markets, Minnesota (2015) (14)
Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000–2008 (2016) (14)
Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites (2013) (14)
Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance (2015) (13)
CDC Grand Rounds: Discovering New Diseases via Enhanced Partnership Between Public Health and Pathology Experts (2014) (13)
Lyme disease surveillance in the United States: Looking for ways to cut the Gordian knot (2018) (13)
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States. (2022) (13)
Burden of Invasive Methicillin‐Resistant Staphylococcus aureus Infections in Nursing Home Residents (2018) (13)
Surveillance for Viral Hepatitis (2008) (13)
Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015 (2017) (13)
1836. Characteristics of Nursing Homes Associated With Self-reported Implementation of Centers for Disease Control and Prevention (CDC) Core Elements of Antibiotic Stewardship (2018) (12)
Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997 (2015) (12)
Recommendations for Prevention and Control of Influenza in Children, 2021–2022 (2021) (12)
Characteristics of Adults Aged 18–49 Years Without Underlying Conditions Hospitalized With Laboratory-Confirmed Coronavirus Disease 2019 in the United States: COVID-NET—March–August 2020 (2020) (12)
COVID-19 Outbreak Associated with a 10-Day Motorcycle Rally in a Neighboring State — Minnesota, August–September 2020 (2020) (12)
A Clustering of Immune-mediated Polyradiculoneuropathy among Swine Abattoir Workers Exposed to Aerosolized Porcine Brains, Indiana, United States (2009) (11)
Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections (2015) (11)
Comparison of influenza and COVID-19–associated hospitalizations among children < 18 years old in the United States—FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021) (2022) (11)
Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic (2020) (11)
Multistate Point-Prevalence Survey of Health Care-Associated Infections. (2022) (11)
Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda (2020) (11)
Notes from the Field: Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera — United States, 2014–2017 (2018) (11)
Risk Factors for SARS-CoV-2 Infection Among US Healthcare Personnel, May–December 2020 (2021) (10)
Active, population‐based surveillance for infectious diseases (2013) (10)
Investigation of SARS-CoV-2 Transmission Associated With a Large Indoor Convention — New York City, November–December 2021 (2022) (10)
HEALTHCARE PROFESSIONAL SURVEYS: JUDICIOUS ANTIBIOTIC USE IN MINNESOTA LONG‐TERM CARE FACILITIES (2007) (10)
Teratogen update: congenital toxoplasmosis. (1995) (10)
Summer outbreak of severe RSV-B disease, Minnesota, 2017 associated with emergence of a genetically distinct viral lineage. (2020) (10)
Multistate fungal meningitis outbreak -- interim guidance for treatment. (2012) (10)
Comparison of Data Collection for Healthcare-Associated Infection Surveillance in Nursing Homes (2016) (9)
Acute Cardiovascular Events Associated With Inﬂuenza in Hospitalized Adults A Cross-sectional Study (2020) (9)
Seasonal influenza morbidity estimates obtained from telephone surveys, 2007. (2013) (9)
Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection (2012) (9)
Census tract socioeconomic indicators and COVID-19-associated hospitalization rates—COVID-NET surveillance areas in 14 states, March 1–April 30, 2020 (2021) (9)
Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011 (2017) (9)
Can we conquer coqueluche? (2014) (9)
Surveillance for HIV/AIDS in the United States (2008) (9)
Invasive pneumococcal strain distributions and isolate clusters associated with persons experiencing homelessness during 2018. (2020) (9)
Pandemic (H1N1) 2009–associated Deaths Detected by Unexplained Death and Medical Examiner Surveillance (2011) (8)
Influenza Antiviral Treatment and Length of Stay (2021) (8)
Methicillin-Resistant Staphylococcus aureus at Canoe Camp (2006) (8)
Novel H1N1 influenza hospitalizations: Minneapolis-St. Paul metropolitan area, 2008-2009. (2009) (7)
Recommended Childhood and Adolescent Immunization Schedule: United States, 2005 (2005) (7)
Effective State-Based Surveillance for Multidrug-Resistant Organisms Related to Health Ca re-Associated Infections (2011) (7)
Addressing emerging infections. The partnership between public health and primary care physicians. (1999) (7)
New Pneumococcal Serotype 15D (2021) (7)
Geotemporal Analysis of Neisseria meningitidis Clones in the United States: 2000–2005 (2013) (7)
Powassan Virus Encephalitis, Minnesota, USA (2013) (7)
Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015 (2017) (7)
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic (2018) (7)
Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 in High-Density Settings, Minnesota, USA, March–June 2020 (2021) (7)
Evaluation of Surveillance Methods for Staphylococcal Toxic Shock Syndrome (2009) (7)
Integrating Host Genomics with Surveillance for Invasive Bacterial Diseases (2008) (6)
Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998-2018. (2020) (6)
Surveillance for Vector‐Borne Diseases (2008) (6)
Influenza-Associated Parotitis During the 2014–2015 Influenza Season in the United States (2018) (6)
Outbreak of Tuberculosis among Guatemalan Immigrants in Rural Minnesota, 2008 (2011) (6)
COVID-19–Associated Hospitalizations Among U.S. Infants Aged <6 Months — COVID-NET, 13 States, June 2021–August 2022 (2022) (6)
Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States. (2022) (5)
Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019 (2021) (5)
Recommended Childhood and Adolescent Immunization Schedule: United States, 2020 (2020) (5)
A cluster of carbapenemase-producing Enterobacter cloacae complex ST171 at a tertiary care center demonstrating an ongoing regional threat. (2016) (5)
Invasive Group A Streptococcal Disease in Nursing Homes, Minnesota, 1995–2006 (2008) (5)
Investigation of Inhalation Anthrax Case (2014) (5)
Establishing Surveillance for Carbapenem-Resistant Enterobacteriaceae in Minnesota, 2012 (2014) (4)
Changes in Incidence and Strains of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections, 2005–2013 (2016) (4)
Smallpox: remembrance of things past, or the coming plague? (2003) (4)
What Is Anthrax? (2022) (4)
Communication of Information About Surveillance: Part 1: Media Communication of Information about Infectious Disease Surveillance and Outbreaks (2008) (4)
The Complexity of the Resurgence of Childhood Vaccine-Preventable Diseases in the United States (2014) (4)
Immunohistochemistry and electrophysiological findings in swine abattoir workers with immune-mediated polyradiculoneuropathy (2018) (4)
Spatial and temporal clustering of patients hospitalized with laboratory-confirmed influenza in the United States. (2020) (4)
Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes-Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2017. (2022) (4)
Thirty-Day Laboratory-Based Surveillance for Carbapenem-Resistant Enterobacteriaceae in the Minneapolis-St. Paul Metropolitan Area (2014) (4)
Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in U.S. Children Over 9 Seasons Following the 2009 H1N1 Pandemic. (2022) (4)
No Change in Methicillin-Resistant Staphylococcus aureus Nasal Colonization Rates Among Minnesota School Children During 2 Study Periods (2008) (4)
A review of multidrug-resistant Enterobacteriaceae. (2011) (4)
1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016 (2018) (3)
Hospital-Acquired Influenza Among Hospitalized Patients, 2011–2015 (2016) (3)
Characterization of Hospitalized Community-Onset Staphylococcus aureus Lower Respiratory Tract Infections Among Generally Healthy Persons 50 Years of Age or Younger (2013) (3)
Rates of severe influenza-associated outcomes among older adults living with diabetes — FluSurv-NET, 2012–2017 (2022) (3)
Prevention of perinatal group B streptococcal disease in Minnesota: results from a retrospective cohort study and new prevention guidelines. (2003) (3)
Utility of Keywords from Chest Radiograph Reports for Pneumonia Surveillance among Hospitalized Patients with Influenza: The CDC Influenza Hospitalization Surveillance Network, 2008–2009 (2016) (3)
Perinatal Group B Streptococcal Disease Prevention, Minnesota (2005) (3)
Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009 (2016) (3)
Chapter 19. Seasonal and Pandemic Influenza Surveillance (2008) (3)
Tick-borne Disease Prevention: Still No Silver Bullet. (2016) (3)
Expedited partner therapy: a new strategy for reducing sexually transmitted diseases in Minnesota. (2009) (3)
The high cost of bath salts: a study of the health care burden of illicit synthetic drug use in Duluth, Minnesota. (2014) (3)
Pediatric S. aureus Isolate Genotypes and Infections from the Dawn of the CA-MRSA (2015) (3)
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected Through the Emerging Infections Program (2020) (3)
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC’s Emerging Infections Program, United States, 2016–2018 (2022) (3)
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015. (2022) (3)
Pandemic A / H 1 N 1 Vaccination in Pregnancy : Risk of Complicated Pandemic A / H 1 N 1 Infection and Evidence for Vaccine Safety in Taiwan (2011) (3)
Public Health Importance of Methicillin-Sensitive Staphylococcus aureus (MSSA): Results From Pilot Surveillance in Five Counties, 2014–2015 (2015) (2)
Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings—ten Emerging Infections Program sites, April–November 2020 (2021) (2)
486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018 (2018) (2)
Chapter 1. Infectious Disease Surveillance: A Cornerstone for Prevention and Control (2008) (2)
The changing epidemiology of MRSA: emergence of community-associated MRSA in Minnesota (2004) (2)
Surveillance for Unexplained Infectious Disease‐Related Deaths (2008) (2)
Biosurveillance of Drug Overdoses and Substance Misuse Treated in Selected Emergency Departments in Minnesota, 2017-2020 (2021) (2)
Evaluation of Surveillance Systems for Early Epidemic Detection (2008) (2)
Invasive Haemophilus influenzae Disease and Antibiotic Susceptibility of Invasive Isolates in Minnesota, 2002-2005 (2007) (2)
Explaining the unexplained: identifying infectious causes of critical illness and death in Minnesota. (2008) (2)
Surveillance for Methicillin‐Resistant Staphylococcus aureus (MRSA) in the Community (2008) (2)
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020. (2023) (2)
1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017 (2018) (2)
Vaccine Preventable Diseases: Part 1: Vaccine Preventable Disease Surveillance (2008) (2)
1831. Point Prevalence and Epidemiology of Antimicrobial Use in US Nursing Homes, 2017 (2018) (2)
Analysis and Interpretation of Reportable Infectious Disease Data (2008) (2)
Genetic diversity of influenza A viruses circulating in pigs between winter and summer in a Minnesota live animal market (2019) (2)
Lessons Learned From the E-cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI) Outbreak Response, Minnesota, 2019-2020 (2021) (2)
Minnesota surveillance for unexplained deaths and critical illnesses of possible infectious cause. (2000) (1)
1341The benefit of early influenza antiviral treatment of pregnant women hospitalized with laboratory-confirmed influenza (2014) (1)
Chapter 3. Active, Population-Based Surveillance for Infectious Diseases (2008) (1)
Clinical and Case Characteristics of Severe Acute Respiratory Illness (SARI) Among Adult Hospitalized Patients, Minnesota, 2013-2015. (2016) (1)
Viral and Bacterial Co-detections in Influenza-Positive Patients Hospitalized with Severe Acute Respiratory Illness — Minnesota, 2013-2015 (2016) (1)
Vaccine Preventable Diseases: Part 2: Public Health Surveillance for Vaccine Adverse Events (2008) (1)
Kingella kingae: An Emerging Pathogen of Acute Osteoarticular Infections in Children: In Reply (2006) (1)
Prevalence and Epidemiology of Healthcare-Associated Infections (HAI) in US Nursing Homes (NH), 2017 (2020) (1)
Age An Emerging Infections Program Study (2014) (1)
Surveillance for Antimicrobial‐Resistant Streptococcus pneumoniae (2008) (1)
Impact of pregnancy on observed sex disparities among adults hospitalized with laboratory‐confirmed influenza, FluSurv‐NET, 2010‐2012 (2017) (1)
137Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI) (2014) (1)
Toxoplasmosis: Newborn screening for congenital toxoplasma infection (2001) (1)
Emerging Infections Program—State Health Department Perspective (2015) (1)
2494. Influenza B Hospitalizations Are Associated With Mortality in Children, FluSurv-NET, 2011–2017 (2018) (1)
Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota (2022) (1)
Emerging Infections Program—20 Years of Achievements and Future Prospects (2015) (1)
Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19. (2023) (1)
Trends in Group B Streptococcal Infections Among Infants <3 Months of Age and the Potential Impact of a Maternal Vaccine in the United States (2006-2014) (2016) (1)
Fatal Human Rabies Infection with Suspected Host-mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021. (2023) (1)
Antimicrobial resistance and judicious antimicrobial use in Minnesota and the United States. (2001) (1)
Chapter 30. Use of Molecular Epidemiology in Infectious Disease Surveillance (2008) (1)
1504. Risk of Influenza-Associated Hospitalization Among Older Adults Living with Diabetes — United States, 2012–2017 (2020) (1)
Temperature and oxygen saturation in skilled nursing facility residents positive for SARS‐CoV‐2 prior to symptom onset (2021) (1)
Vaping, lung injury, and mental health Minnesota 2018-2019. (2021) (1)
1800Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae (2014) (1)
Future Directions in Infectious Disease Surveillance (2013) (1)
Lessons from Queens. (2010) (1)
ICD-9 code reporting among patients from the Minnesota SARI surveillance program (2017) (1)
Communication of Information About Surveillance: Part 2: Case Study: A Healthy Response to Increases in Syphilis in San Francisco (2008) (1)
Analysis and Interpretation of Case‐Based HIV/AIDS Surveillance Data (2008) (1)
507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017 (2019) (1)
Electronic Reporting in Infectious Disease Surveillance: Part 1: Basic Principles of Electronic Public Health Surveillance (2008) (1)
Clinical Features and Outcomes of Immunocompromised Adults Hospitalized with Laboratory-confirmed Influenza in the USA, 2011–2015 (2017) (0)
Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015 (2017) (0)
Prevalence of Respiratory Viral Pathogen Testing and Co-Detections Among Patients Hospitalized With Influenza, 2012–2015 (2016) (0)
86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020 (2022) (0)
Miscellaneous Advances in Vaccinology (2017) (0)
SocioeconomicandRacial/EthnicDisparitiesintheIncidence ofBacteremicPneumoniaAmongUSAdults (2010) (0)
Healthcare-Associated Infections in U.S. Nursing Homes: Results from a Prevalence Survey Pilot - (CHANGE, presenting author) (2015) (0)
647Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States (2014) (0)
Antimicrobial Nonsusceptibility Among Invasive MRSA USA300 Strains by Healthcare Exposure, Three Sites, 2005–2016 (2020) (0)
Lyme disease; challenges and innovations (2011) (0)
Utilization of Whole Genome Sequencing to Understand SARS-CoV-2 Transmission Dynamics in Long-Term Care Facilities, Correctional Facilities and Meat Processing Plants in Minnesota, March - June 2020 (2021) (0)
Presentation_1_Genomic Surveillance of Streptococcus pyogenes Strains Causing Invasive Disease, United States, 2016–2017.pdf (2020) (0)
Community-acquired methicillin-resistant Staphylococcus aureus. Authors' reply (2004) (0)
2054. Trends in Incidence and Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection, 2005–2020 (2022) (0)
357Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in Georgia, Minnesota, and Oregon – 2012 (2014) (0)
State and Local Health Departments (2018) (0)
Documentation of acute change in mental status in nursing homes highlights opportunity to augment infection surveillance criteria (2020) (0)
Chapter 13. Surveillance for Healthcare-Associated Infections (2008) (0)
Secondary Cases of Invasive Disease Caused by Encapsulated and Nontypeable Haemophilus influenzae — 10 U.S. Jurisdictions, 2011–2018 (2023) (0)
1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013 (2018) (0)
2462. Public Health Response to Contain the First Outbreak of New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in Minnesota (2019) (0)
898. Influenza Vaccination Reduces Risk of Severe Outcomes among Adults Hospitalized with Influenza A(H1N1)pdm09, FluSurv-NET, 2013–2018 (2019) (0)
Does Influenza Vaccination Modify Influenza Disease Severity? Data on Adults Hospitalized With Influenza During the 2013–14 Season in the United States (2015) (0)
Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014 (2017) (0)
111. Pediatric and Adolescent Sepsis Epidemiology and Clinical Characteristics, Emerging Infections Program, 2014–2015 (2019) (0)
Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022. (2023) (0)
Beyond Overdose: Surveillance of Recreational Drug Use and Corresponding Toxicology Testing (2019) (0)
1399Laboratory Characterization and Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) in Hennepin and Ramsey Counties, Minnesota, 2012-2013 (2014) (0)
Community-Associated MRSA (2005) (0)
715. Increase in Reported Respiratory Syncytial Virus Cases Among Adults in the Minneapolis-St. Paul Metropolitan Area, 2014–2018 (2018) (0)
Hepatitis E Virus and Porcine-derived Heparin (2019) (0)
Training in Applied Epidemiology and Infectious Disease Surveillance: Contributions of the Epidemic Intelligence Service (2008) (0)
Infectious Disease I - Rapid-Fire (2016) (0)
On Ebola watch. A conversation with Minnesota's top disease-trackers. (2014) (0)
Comparing Pandemic 2009 H1N1 and Seasonal Influenza A Hospitalizations in the Minneapolis-St. Paul Metropolitan Area (MSP), Minnesota (2009) (0)
Distinct origins and transmission pathways of blaKPC Enterobacterales across three U.S. states (2022) (0)
Rhinovirus-Associated Pediatric Hospitalizations in the Minnesota Severe Acute Respiratory Illness Surveillance System, 2013-2015 (2015) (0)
Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020 (2023) (0)
Epidemiology of Sepsis in U.S. Children and Young Adults (2023) (0)
Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections - United States, 2017-2020. (2023) (0)
Human Activity and Infectious Disease Outbreaks: Can Insight Impact the Trajectory? (2017) (0)
Electronic Reporting in Infectious Disease Surveillance: Part 2: Electronic Clinical Laboratory Reporting for Public Health Surveillance (2008) (0)
The Netherlands' Infectious Diseases Surveillance Information System (ISIS) (2008) (0)
Cluster of Community-Associated Methicillin-Resistant Staphylococcus aureus Infections among Campers (2005) (0)
1059. Staphylococcus aureus Bacteremia Treatment: Results From Pilot Surveillance in Four US States (2018) (0)
Critical and Fatal Infections Due to Community-Associated Staphylococcus aureus, 9 Years of Surveillance in Minnesota (2015) (0)
Surveillance for Tuberculosis in Europe (2008) (0)
Software Applications for Analysis of Surveillance Data (2008) (0)
Carbapenem Resistance in Enterobacteriaceae: Trends from Active, Population-Based Surveillance Using Automated Testing Instrument Queries in Hennepin and Ramsey Counties, Minnesota, 2013 - 2015 (2016) (0)
Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019 (2022) (0)
Toxoplasmosis (1997) (0)
Socioeconomic factors explain racial disparities in community-associated methicillin-resistant Staphyloccocus aureus disease rates (2015) (0)
1925. Prevalence of SARS-CoV-2 Infection in Immunocompromised Patients Following Receipt of Tixagevimab/Cilgavimab (2022) (0)
Comprar Infectious Disease Surveillance | Andrea Fontana | 9781405142663 | Wiley (2009) (0)
Carbapenem-Resistant Enterobacteriaceae Screening in Patients with Healthcare Exposure Outside the United States: Practices in Acute Care Facilities in Hennepin and Ramsey Counties, Minnesota (2018) (0)
Highly Pathogenic Avian Influenza in North America—What Is Going On? (2015) (0)
Implementing Syndromic Surveillance Systems in the Climate of Bioterrorism (2008) (0)
Influenza C Detection Among Patients Hospitalized with Severe Acute Respiratory Illness, Minnesota 2014–2015 (2015) (0)
Invasive Staphylococcus aureus Infections: a Large Role for MSSA (2015) (0)
Lessons Learned from Smallpox Eradication and Severe Acute Respiratory Syndrome Outbreak: Part 1: The use of Surveillance in the Eradication of Smallpox and Poliomyelitis (2008) (0)
LB17. Age-Related Differences in Influenza Type/Subtype Among Patients Hospitalized with Influenza, FluSurv-NET—2017–2018 (2018) (0)
Comparison of Respiratory Pathogen Detections from Routine Hospital Testing and Expanded Systematic Testing from the Minnesota Severe Acute Respiratory Illness Surveillance Program, 2015–2016 (2017) (0)
Infectious Disease I (2015) (0)
Intent among Parents to Vaccinate Children before Pediatric COVID-19 Vaccine Recommendations, Minnesota and Los Angeles County, California—May–September 2021 (2022) (0)
Notes from the Field: Increase in Pediatric Invasive Group A Streptococcus Infections — Colorado and Minnesota, October–December 2022 (2023) (0)
Surveillance for Agents of Bioterrorism in the United States (2008) (0)
Assessing Pathogen Transmission Opportunities: Variation in Nursing Home Staff-Resident Interactions. (2023) (0)
Epidemiology of meningococcal disease in the United States, 1997-2002 (2004) (0)
Vaccine effectiveness against influenza-associated hospitalization among children aged < 13 years using a hospital-based surveillance system in Minnesota, 2013 – 2016 (2017) (0)
Bacterial Infections: A Preparedness Study (2014) (0)
Communicable Disease Surveillance in Complex Emergencies (2008) (0)
Public Health Chronicles (2007) (0)
982. Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 (2018) (0)
LB19. Patterns of Influenza A Hospitalizations by Subtype and Age in the United States, FluSurv-NET, 2018–2019 (2019) (0)
Infectious Disease III (2014) (0)
Rapid onset of functional tic-like behaviors among adolescent girls—Minnesota, September–November 2021 (2023) (0)
Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections in Four U.S. Emerging Infections Program Sites: A Six-Month Pilot. (2023) (0)
1621. Acute Cardiovascular Events Among Adults Hospitalized with Influenza, FluSurv-NET, 2010–2018 (2019) (0)
2797. Rates of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Adults by Congestive Heart Failure Status—United States, 2015–2017 (2019) (0)
Minnesota One Health Antibiotic Stewardship Collaborative: A Reproducible Approach to Facilitate Antimicrobial Stewardship Progress (2022) (0)
RSV disease burden among children under two years of age in the United States (2017) (0)
Legal Considerations in Surveillance, Isolation, and Quarantine: Part 1: Legal Basis for Infectious Disease Surveillance and Control (2008) (0)
1718Resistance among Invasive Group A Streptococcal Infections, United States, 1999-2012 (2014) (0)
128. Characteristics and Outcomes of Pregnant Women Hospitalized with Influenza in the United States, Flusurv-net, 2010–2019 (2020) (0)
cacy and adverse events of experimental drugs. Ongoing studies will inform appropriate use of new agents in the future. (2013) (0)
Chapter 2. Infectious Disease Surveillance and the International Health Regulations (2008) (0)
Classical Swine Influenza A Infection in a Minnesota Swine Worker During the H1N1 Novel Influenza Outbreak, May 2009 (2009) (0)
New York State International Training Program for Fogarty Fellows (2008) (0)
for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the United States . Running title : DNA sequence based antimicrobial susceptibility and capsular serotype predictions (2017) (0)
Characteristics of healthcare personnel who reported concerns related to PPE use during care of COVID-19 patients (2022) (0)
527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia (2021) (0)
180. Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States (2020) (0)
94. Pneumonia Severity Scores Poorly Predict Severe Outcomes Among Adults Hospitalized with Influenza (2019) (0)
Characteristics of clinical extrapulmonary nontuberculous mycobacteria isolates in Minnesota, 2013-2017. (2020) (0)
186. Characteristics of COVID-19 Vaccine Breakthrough Cases in Minnesota, 2021 (2021) (0)
Case Definitions and Data Collected (0)
Effectiveness of Screening and Decolonization of Staphylococcus aureus in Surgery Outpatients (2015) (0)
469. Contributions of Infections among Persons Who Inject Drugs to the Changing Incidence of Healthcare-Associated, Community-Onset Methicillin-Resistant Staphylococcus aureus Infections, 2009–2017 (2019) (0)
Antibiotic Susceptibility of Common Organisms Isolated from Urine Cultures of Nursing Home Residents (2020) (0)
Evaluation of Care Interactions Between Healthcare Personnel and Residents in Nursing Homes Across the United States (2020) (0)
Highlighting the Role of Public Health (2016) (0)
Why HIV still matters in Minnesota. (2009) (0)
Appropriateness of Initiating Antibiotics for Urinary Tract Infection Among Nursing Home Residents (2020) (0)
79Prevention of Antimicrobial Resistant Infection Among Children Aged <5 Years with the 13-valent Pneumococcal Conjugate Vaccine – Selected U.S. Areas, 2005–2013 (2014) (0)
1408. Population-based Nontuberculous Mycobacteria Surveillance in Four Emerging Infections Program Sites, October 2019–March 2020 (2021) (0)
Use of the World Wide Web to Enhance Infectious Disease Surveillance (2008) (0)
1009. Measuring the quality of fluoroquinolone prescribing in hospitals: results from the Emerging Infections Program Hospital Prevalence Survey Antimicrobial Quality Assessment (2019) (0)
Surveillance for Antimicrobial Resistance Among Foodborne Bacteria: The US Approach (2008) (0)
Invasive Methicillin-Resistant Staphylococcus aureus Infections in Residents of Long-Term Care Facilities: Targeted Prevention Efforts Needed (2015) (0)
PandemicInfluenza:ImplicationsforProgramsControlling forHIVInfection,Tuberculosis,andChronicViralHepatitis (2009) (0)
Supranational Surveillance in the European Union (2008) (0)
685. Correlation Between Hospitalized Influenza and Group A Streptococcus Infections in Minnesota, 2010–2016 (2018) (0)
Effectiveness of Antiviral Treatment Among Children Hospitalized With Laboratory-Confirmed Influenza (2015) (0)
1859. Prevalence of Antimicrobial Use in US Hospital Patients, 2011 vs. 2015 (2018) (0)
Questions & Answers: Rapid Fire: Vaccine-Preventable Diseases III (2016) (0)
Epidemiology and Prevention of Infectious Diseases (2014) (0)
1712. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in Children in the post-2009 Pandemic Era (2020) (0)
356Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program (2014) (0)
Lessons Learned from Smallpox Eradication and Severe Acute Respiratory Syndrome Outbreak: Part 2: SARS Surveillance in Hong Kong and the United States during the 2003 Outbreak (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ruth Lynfield?

Ruth Lynfield is affiliated with the following schools:

Emory University
Massachusetts General Hospital